🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There is sound evidence that quetiapine is effective in the treatment of ma...
Status
Unknown
Location
Hospital de Clinicas de Porto Alegre
Start Date
2009-03
Trial ID
NCT00879307
Treatments Being Tested
The purpose of this study was to evaluate the efficacy, safety, and pharmac...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-18
Trial ID
NCT02362412
Treatments Being Tested
Patients eligible for entry into the study have a diagnosis of schizophreni...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00921362
This study is being carried out to see if quetiapine (Seroquel) is effectiv...
Status
Completed
Location
Investigative Site
Start Date
2005-03
Trial ID
NCT00228462
Treatments Being Tested
The purpose of this study is to gather information about the steady-state p...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02087579
Purpose: We are proposing to examine, via open label trial, the use of Sero...
Status
Completed
Location
UNC Center for Functional GI & Motility Disorders
Start Date
2008-02
Trial ID
NCT00617396
Treatments Being Tested
This study is designed to describe asenapine prescribing patterns in the Un...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-01
Trial ID
NCT01498770
This study will test the effectiveness of two different treatments for chil...
Status
Completed
Location
University of Maryland
Start Date
2009-01
Trial ID
NCT00806234
The benefits and harms of antipsychotics are relatively well studied in adu...
Status
Completed
Location
Aalborg Psychiatric Hospital
Start Date
2010-05
Trial ID
NCT01119014
Treatments Being Tested
A Clinical Study that will look at an investigational medication, SEP-36385...
Status
Completed
Location
Woodland International Research Group
Start Date
2022-11-15
Trial ID
NCT05542264
Treatments Being Tested